Nuvectis Pharma Announces Public Share Offering
Nuvectis Pharma (NVCT) has launched an underwritten public offering of its common stock with a 30-day option for underwriters to purchase up to an additional 15% of the shares. The move aims to raise capital, likely supporting ongoing drug development programs.
